Haemonetics Sets Date for Q2 FY2027 Financial Results Release

BOSTON, Sept. 30, 2026 /CourierPR/ -- Haemonetics Corporation, a global medical technology company, is set to release its second quarter fiscal year 2027 financial results on Thursday, November 5, 2026, at 6:00 a.m. Eastern Time. The company will host a conference call for investors and analysts at 8:00 a.m. Eastern Time on the same day. The call will be accessible via teleconference, and participants are advised to join 10 minutes prior to the event start.

Haemonetics Corporation, headquartered in Boston, Massachusetts, will provide a detailed overview of its financial performance during the call. The company is known for its Apheresis business, which includes proprietary technologies designed to enhance safety, yield, donor satisfaction, and operational efficiency for plasma and blood collectors worldwide. Additionally, Haemonetics offers Blood Management Technologies to assist in making informed treatment decisions and optimizing the management of blood products, as well as Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, aimed at improving procedural effectiveness and the patient experience.

Participants can join the conference call by registering at the designated link, which will provide a dial-in number and a personalized PIN. A live webcast of the call will also be available on Haemonetics' investor relations website, accessible through the provided link. A replay of the conference call and webcast will be available for one year, starting from November 5, 2026, at 11:00 a.m. Eastern Time, and can be accessed using the same link.

Haemonetics Corporation is dedicated to improving the quality, effectiveness, and efficiency of healthcare. The company's focus on innovation and technology continues to drive its mission to enhance patient care and operational excellence in the medical field.